Obesity News

Adults with obesity who report less social isolation and loneliness have a lower risk for all-cause mortality, according to findings published in JAMA Network Open.

The risk for all-cause mortality decreases among patients with knee or hip osteoarthritis who achieve slow-to-moderate, but not fast, weight loss via anti-obesity medications, according to data published in Arthritis & Rheumatology.

Researchers identified a positive association between consumption of 100% fruit juice and weight gain in children, according to study results published in JAMA Pediatrics.

Adults using semaglutide for type 2 diabetes or obesity treatment are at a lower risk for suicidal ideation than adults using non-GLP-1 receptor agonists, according to recent findings.

An increase in symptoms of depression was linked to a small increase in weight among adults with overweight or obesity, according to a recent study in PLOS One.

Preliminary results from an ongoing FDA investigation found no evidence that weight-loss drugs cause suicidal ideations and aspirations, although the agency said it cannot rule out a risk entirely.

Exposure to plastics containing endocrine-disrupting chemicals added an estimated $249 billion to health care costs in the U.S. in 2018, according to study data.

In the landscape of health care, the year 2023 witnessed remarkable strides in the field of obesity medicine.

Eli Lilly and Co. urged consumers not to use tirzepatide for cosmetic weight loss and to avoid compounded and counterfeit versions of the drug.

An FDA investigation of popular weight-loss drugs has generated a storm of media attention and prompted patient questions.